The effectiveness of metacognitive therapy and reality therapy on self-care behavior, quality of life, depression and biological variables in patients with type 2 diabetes
- Conditions
- Diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20200916048737N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 75
Completion and signing of written consent by the subject
No abuse of drugs and psychotropic drugs
Age between 30-60 years
More than a year has passed since the diagnosis of type 2 diabetes
The minimum depression score is 8
Fasting sugar should not exceed 135 mg per deciliter
HbA1c should not exceed 8%
Failure to receive psychological treatment during the last 3 months
Absence of severe physical diseases caused by diabetes such as kidney failure, vision and ...
Development of severe physical diseases caused by diabetes such as kidney failure, vision and ...
Receiving psychological therapies during the intervention
Consumption of any sedative or neuropsychiatric drugs
Increase in the dose of diabetes-related drugs
More than two absences
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression. Timepoint: Before the intervention, immediately after the intervention and one month and three months later. Method of measurement: Beck Depression Inventory.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: Before the intervention, immediately after the study and one month and three months later. Method of measurement: SF36 Health Status Questionnaire.;Self care. Timepoint: Before the intervention, immediately after the study and one month and three months later. Method of measurement: Tobert and Glasgow Self-Care Questionnaire.;Fasting blood sugar. Timepoint: Before the intervention, immediately after the study and one month and three months later. Method of measurement: blood test.;Glycosylated hemoglobin. Timepoint: Before the intervention, immediately after the study and one month and three months later. Method of measurement: Blood test.;Blood pressure. Timepoint: Before the intervention, immediately after the study and one month and three months later. Method of measurement: Analog blood pressure monitor.